Manulife signs reinsurance deal with Global Atlantic, plans to buy back shares
Manulife said the deal is expected to release $1.2 billion of capital
By The Canadian Press |December 11, 2023
1 min read
Long-term care (LTC) insurance, available in Canada since the early 1990s, is sold in roughly 30 countries around the world as, similar to Canada, many markets are facing issues related to an aging population. Countries such as Germany, Japan and Singapore have recognized the impact LTC needs will have in the future and have introduced mandatory, publicly funded LTC insurance to cope with the burden an aging population will have on their populations.
Here are some staggering facts about the Canadian population: one out of every two Canadians aged 65 and over will have some type of disability, and 43% will need nursing home care at some point in their lives. At age 85-plus, the disability rate increases to 70%.
When it comes to LTC insurance, the underwriting process is unlike any other type of underwriting in the life insurance industry. This may partially explain why some advisors are more reticent to market the product — a lack of understanding of what exactly the insurer is trying to assess in an applicant.
Cognitive screening
Cognitive screening is a crucial aspect of LTC underwriting. In its early stages, cognitive impairment can be very subtle, and as a result, a medical record alone may give little information that would suggest an early decline in cognitive functioning.
The use of objective, standardized cognitive tools can help discern those who may be experiencing early cognitive loss. The industry has rapidly trended toward a third-generation cognitive screen — the enhanced mental skills test (EMST) — that has high sensitivity and specificity in the detection of mild cognitive impairment (MCI). This screening tool is based upon the widely researched CERAD (Consortium to Establish a Registry for Alzheimer’s Disease) battery, which is widely acknowledged as the gold standard for dementia testing.
The EMST tests all key domains relevant to identifying MCI. These include executive function (abstract reasoning, judgment, insight and concept organization), working and episodic memory, comprehension, attention, concentration and language. The EMST’s scoring is based on multiple factors that enhance its sensitivity and specificity in screening for the very earliest stages of cognitive decline. These include the number of words recalled during word trials, their order and any changes in performance when recalling a word across working and episodic memory trials and a person’s insight into his or her own memory ability.
Determining functional capacity
Some of the best predictors of long-term care use are those related to functional capacity. Two types of functioning are important:
1. The ability to perform activities of daily living (ADLs)
The index of independence in activities of daily living (index of ADL) has a long history of extensive use by clinicians as the best measure for functional disability and is an accepted standard in the field of geriatrics and functional assessment. Bathing, dressing, toileting, transferring, continence and feeding make up the well-known Katz index of ADL. The ADLs are listed hierarchically according to the order in which people tend to lose their ability to perform them. A person who has two ADL dependencies is most likely to require assistance with bathing and dressing.
2. The ability to perform instrumental activities of daily living (IADLs)
Instrumental activities of daily living refer to social survival skills that must be performed either on a household or an individual basis. Commonly measured IADLs include the ability to:
IADL functions tend to be complex, requiring a combination of physical and cognitive capacities. For example, shopping requires mobility and a relatively intact cognition to handle the financial transactions involved. Loss of IADLs are, in some ways, a precursor to future loss of ADLs.
The ability to perform certain IADLs may be gender-related, in that women have traditionally performed some of the activities, while men have more commonly performed others. What matters is not only whether a person currently performs an activity but also whether he or she is capable of performing it if required to do so for an extended period of time — without assistance.
The interview process as part of underwriting
Personal history interviews (PHIs), usually over the phone, are being used for younger applicants while face-to-face interviews (FTFs) are conducted with older applicants (aged 70-plus). General information questions, such as those about employment, hobbies, activities and living arrangements, are asked to provide a basic understanding of the applicant. Medical questions are also used both to confirm application details and to elicit additional information on medical history. The applicant will be asked to provide a list of all prescriptions and over-the-counter medications taken and describe any medical equipment being used. In the case of FTFs, the assessor may also record the applicant’s height, weight and blood pressure.
The applicant is also asked to participate in a cognitive exercise — such as the EMST as described above — to determine if there is any underlying impairment that will affect future memory function. The remainder of the assessment relates to questions about performing daily activities (ADLs and IADLs.
At the end of the interview, the applicant will be asked to sign and date the face-to-face interview form. The assessor may ask to see a form of picture identification, such as a driver’s licence or passport to verify the signature.
Along with the interview, medical records obtained from attending physicians complete the risk assessment process.
Industry practices
Most insurers are using the EMST as their screening tool for cognitive decline. This screen is easily administered and takes into account age, gender and education level as part of its complex algorithm to accurately determine underlying memory impairment.
Now, let’s look at two case studies.
On March 22, 2008, a 71-year-old male applied for a $3,000 per month, three-year benefit duration, 90-day elimination period home care and facility care policy.
His application denied any medication use and stated that his last doctor’s visit occurred earlier in the month for a sore shoulder. The agent described him as active and independent. A telephone interview revealed the applicant remained medication-free and that the strained shoulder was treated with exercise. He reported being independent and he passed the cognitive portion of the interview.
The medical records confirmed his shoulder self-report and also indicated a history of prostate cancer with no metastasis in 2005 and degenerative arthritis in his right knee with no limitations. His application was approved.
On March 11, 2008, a 77-year-old female applied for a $1,500/month, lifetime benefit duration, 30-day elimination period comprehensive policy.
Her application indicated a history of hypertension treated with Hyzaar and Tiazac, as well as an episode of shortness of breath in May 2007. No details were supplied for this episode or the diagnosis. Her last doctor’s visit occurred in February 2008 for a routine examination.
During an in-person interview, she reported that her hypertension had been controlled since 1990. Along with the medications noted on her application, she also revealed taking lycopene, Nexium, Clonazepam, Zocor and Combivent. She also admitted a history of forgetfulness and memory loss for which she consulted her doctor but did not recall the complete details of the conversation.
The assessor noted she was distracted, had wandering thoughts and had trouble remaining focused throughout the interview. She did not pass the cognitive exercise. Medical records were cancelled because she was uninsurable based on cognitive results and reports of forgetfulness/memory loss. Her application was declined.
If you would like to learn more about LTC, plan to attend Canada’s first Long-Term Care Conference brought to you by Munich Re on Oct. 21. Follow this link for more details.
Hélène Michaud is assistant vice-president, marketing, at Munich Re.
(08/19/09)
Long-term care (LTC) insurance, available in Canada since the early 1990s, is sold in roughly 30 countries around the world as, similar to Canada, many markets are facing issues related to an aging population. Countries such as Germany, Japan and Singapore have recognized the impact LTC needs will have in the future and have introduced mandatory, publicly funded LTC insurance to cope with the burden an aging population will have on their populations.
Here are some staggering facts about the Canadian population: one out of every two Canadians aged 65 and over will have some type of disability, and 43% will need nursing home care at some point in their lives. At age 85-plus, the disability rate increases to 70%.
When it comes to LTC insurance, the underwriting process is unlike any other type of underwriting in the life insurance industry. This may partially explain why some advisors are more reticent to market the product — a lack of understanding of what exactly the insurer is trying to assess in an applicant.
Cognitive screening
Cognitive screening is a crucial aspect of LTC underwriting. In its early stages, cognitive impairment can be very subtle, and as a result, a medical record alone may give little information that would suggest an early decline in cognitive functioning.
The use of objective, standardized cognitive tools can help discern those who may be experiencing early cognitive loss. The industry has rapidly trended toward a third-generation cognitive screen — the enhanced mental skills test (EMST) — that has high sensitivity and specificity in the detection of mild cognitive impairment (MCI). This screening tool is based upon the widely researched CERAD (Consortium to Establish a Registry for Alzheimer’s Disease) battery, which is widely acknowledged as the gold standard for dementia testing.
The EMST tests all key domains relevant to identifying MCI. These include executive function (abstract reasoning, judgment, insight and concept organization), working and episodic memory, comprehension, attention, concentration and language. The EMST’s scoring is based on multiple factors that enhance its sensitivity and specificity in screening for the very earliest stages of cognitive decline. These include the number of words recalled during word trials, their order and any changes in performance when recalling a word across working and episodic memory trials and a person’s insight into his or her own memory ability.
Determining functional capacity
Some of the best predictors of long-term care use are those related to functional capacity. Two types of functioning are important:
1. The ability to perform activities of daily living (ADLs)
The index of independence in activities of daily living (index of ADL) has a long history of extensive use by clinicians as the best measure for functional disability and is an accepted standard in the field of geriatrics and functional assessment. Bathing, dressing, toileting, transferring, continence and feeding make up the well-known Katz index of ADL. The ADLs are listed hierarchically according to the order in which people tend to lose their ability to perform them. A person who has two ADL dependencies is most likely to require assistance with bathing and dressing.
2. The ability to perform instrumental activities of daily living (IADLs)
Instrumental activities of daily living refer to social survival skills that must be performed either on a household or an individual basis. Commonly measured IADLs include the ability to:
IADL functions tend to be complex, requiring a combination of physical and cognitive capacities. For example, shopping requires mobility and a relatively intact cognition to handle the financial transactions involved. Loss of IADLs are, in some ways, a precursor to future loss of ADLs.
The ability to perform certain IADLs may be gender-related, in that women have traditionally performed some of the activities, while men have more commonly performed others. What matters is not only whether a person currently performs an activity but also whether he or she is capable of performing it if required to do so for an extended period of time — without assistance.
The interview process as part of underwriting
Personal history interviews (PHIs), usually over the phone, are being used for younger applicants while face-to-face interviews (FTFs) are conducted with older applicants (aged 70-plus). General information questions, such as those about employment, hobbies, activities and living arrangements, are asked to provide a basic understanding of the applicant. Medical questions are also used both to confirm application details and to elicit additional information on medical history. The applicant will be asked to provide a list of all prescriptions and over-the-counter medications taken and describe any medical equipment being used. In the case of FTFs, the assessor may also record the applicant’s height, weight and blood pressure.
The applicant is also asked to participate in a cognitive exercise — such as the EMST as described above — to determine if there is any underlying impairment that will affect future memory function. The remainder of the assessment relates to questions about performing daily activities (ADLs and IADLs.
At the end of the interview, the applicant will be asked to sign and date the face-to-face interview form. The assessor may ask to see a form of picture identification, such as a driver’s licence or passport to verify the signature.
Along with the interview, medical records obtained from attending physicians complete the risk assessment process.
Industry practices
Most insurers are using the EMST as their screening tool for cognitive decline. This screen is easily administered and takes into account age, gender and education level as part of its complex algorithm to accurately determine underlying memory impairment.
Now, let’s look at two case studies.
On March 22, 2008, a 71-year-old male applied for a $3,000 per month, three-year benefit duration, 90-day elimination period home care and facility care policy.
His application denied any medication use and stated that his last doctor’s visit occurred earlier in the month for a sore shoulder. The agent described him as active and independent. A telephone interview revealed the applicant remained medication-free and that the strained shoulder was treated with exercise. He reported being independent and he passed the cognitive portion of the interview.
The medical records confirmed his shoulder self-report and also indicated a history of prostate cancer with no metastasis in 2005 and degenerative arthritis in his right knee with no limitations. His application was approved.
On March 11, 2008, a 77-year-old female applied for a $1,500/month, lifetime benefit duration, 30-day elimination period comprehensive policy.
Her application indicated a history of hypertension treated with Hyzaar and Tiazac, as well as an episode of shortness of breath in May 2007. No details were supplied for this episode or the diagnosis. Her last doctor’s visit occurred in February 2008 for a routine examination.
During an in-person interview, she reported that her hypertension had been controlled since 1990. Along with the medications noted on her application, she also revealed taking lycopene, Nexium, Clonazepam, Zocor and Combivent. She also admitted a history of forgetfulness and memory loss for which she consulted her doctor but did not recall the complete details of the conversation.
The assessor noted she was distracted, had wandering thoughts and had trouble remaining focused throughout the interview. She did not pass the cognitive exercise. Medical records were cancelled because she was uninsurable based on cognitive results and reports of forgetfulness/memory loss. Her application was declined.
If you would like to learn more about LTC, plan to attend Canada’s first Long-Term Care Conference brought to you by Munich Re on Oct. 21. Follow this link for more details.
Hélène Michaud is assistant vice-president, marketing, at Munich Re.
(08/19/09)